Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma

[1]  I. Ong,et al.  PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis , 2017, Nature Cell Biology.

[2]  Nicholas W. Kwiecien,et al.  Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition , 2017, Nature Communications.

[3]  Zhongyong Zhou,et al.  miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1 , 2017, OncoTargets and therapy.

[4]  C. Arrowsmith,et al.  Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6. , 2016, Journal of medicinal chemistry.

[5]  P. Ahlquist,et al.  CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis. , 2016, Cancer cell.

[6]  Matthieu Schapira,et al.  Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening. , 2016, Journal of medicinal chemistry.

[7]  Jodi Gureasko,et al.  CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism. , 2016, Biochemistry.

[8]  Robert A Copeland,et al.  A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. , 2015, Nature chemical biology.

[9]  Tim J. Wigle,et al.  Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound. , 2015, ACS medicinal chemistry letters.

[10]  Tim J. Wigle,et al.  Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma , 2014, Molecular Cancer Therapeutics.

[11]  A. Melnick,et al.  PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex. , 2013, Cell reports.

[12]  Satoru Takahashi,et al.  Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis. , 2013, Oncology reports.

[13]  H. Fan,et al.  Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes , 2013, Diagnostic Pathology.

[14]  M. Gorospe,et al.  Loss of CARM1 is linked to reduced HuR function in replicative senescence , 2013, BMC Molecular Biology.

[15]  Tim J. Wigle,et al.  Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 , 2013, Proceedings of the National Academy of Sciences.

[16]  Yan Liu,et al.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.

[17]  J. Wong,et al.  A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin , 2012, PloS one.

[18]  A. Mai,et al.  Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity. , 2011, Journal of Medicinal Chemistry.

[19]  Yonghong Xiao,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[20]  K. Kish,et al.  Structural basis for CARM1 inhibition by indole and pyrazole inhibitors. , 2011, The Biochemical journal.

[21]  Jeong Hoon Kim,et al.  A Coactivator Role of CARM1 in the Dysregulation of β-Catenin Activity in Colorectal Cancer Cell Growth and Gene Expression , 2011, Molecular Cancer Research.

[22]  Y. Blat.  Non‐Competitive Inhibition by Active Site Binders , 2010, Chemical biology & drug design.

[23]  Eric Therrien,et al.  1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). , 2009, Bioorganic & medicinal chemistry letters.

[24]  S. Pang,et al.  Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies. , 2009, Bioorganic & medicinal chemistry letters.

[25]  S. Pang,et al.  Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). , 2009, Bioorganic & medicinal chemistry letters.

[26]  S. Wolf.  The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans , 2009, Cellular and Molecular Life Sciences.

[27]  Eric Therrien,et al.  N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). , 2009, Bioorganic & medicinal chemistry letters.

[28]  S. Pang,et al.  Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). , 2008, Bioorganic & medicinal chemistry letters.

[29]  V. Iyer,et al.  CARM1 promotes adipocyte differentiation by coactivating PPARγ , 2008, EMBO reports.

[30]  Mathieu Lupien,et al.  CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. , 2008, Cancer research.

[31]  J. Côté,et al.  The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. , 2007, Molecular cell.

[32]  J. Torchia,et al.  The Activity and Stability of the Transcriptional Coactivator p/CIP/SRC-3 Are Regulated by CARM1-Dependent Methylation , 2006, Molecular and Cellular Biology.

[33]  J. Mohler,et al.  Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability , 2006, The Prostate.

[34]  M. Rosenfeld,et al.  Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Robert A Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.

[36]  Lang Li,et al.  Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status , 2004, Cancer.

[37]  M. Stallcup,et al.  Developmentally Essential Protein Flightless I Is a Nuclear Receptor Coactivator with Actin Binding Activity , 2004, Molecular and Cellular Biology.

[38]  M. Hu,et al.  Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Chuong,et al.  Synergistic Coactivator Function by Coactivator-associated Arginine Methyltransferase (CARM) 1 and β-Catenin with Two Different Classes of DNA-binding Transcriptional Activators* , 2002, The Journal of Biological Chemistry.

[40]  M. Bedford,et al.  PABP1 identified as an arginine methyltransferase substrate using high‐density protein arrays , 2002, EMBO reports.

[41]  D. Aswad,et al.  Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. , 2001, Biochemistry.

[42]  W Ruf,et al.  Exosite Interactions Determine the Affinity of Factor X for the Extrinsic Xase Complex* , 2000, The Journal of Biological Chemistry.